Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-γ-expressing Th1-like cells and up-regulation of TGF-β mRNA in mononuclear cells

Annals of the New York Academy of Sciences

Volumn 778, Issue , 1996, Pages 273-287

  Ma, Cun Gen ^a   Zhang, Guang Xian ^a   Xiao, Bao Guo ^a   Wang, Zeng Yu ^a   Link, Joanne ^a   Olsson, Tomas ^a   Link, Hans ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOKINE; FREUND ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA; NICOTINIC RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; HELPER CELL; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IN SITU HYBRIDIZATION; LYMPHOID ORGAN; MONONUCLEAR CELL; MOUTH MUCOSA; MYASTHENIA GRAVIS; NONHUMAN; NOSE MUCOSA; OLIGONUCLEOTIDE PROBE; RAT; T LYMPHOCYTE;

EID: 0029915770     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb21135.x     Document Type: Article

References (30)

1. LINDSTROM, J., D. SHELTON & Y. FUJII. 1988. Myasthenia gravis. Adv. Immunol. 42: 233.
2. DRACHMAN, D. B. 1994. Myasthenia gravis. N. Engl. J. Med. 330: 1797.
3. HOHLFELD, R., I. KALIES, B. KOHLEISEN, K. HEININGER, B. CONTI-TRONCONI & K. V. TOYKA. 1986. Myasthenia gravis: Stimulation of antireceptor autoantibodies by autoreactive T cell lines. Neurology 36: 618.
4. BACH, J. F. 1993. Immunosuppressive therapy of autoimmune diseases. Immunol. Today 14: 322.
5. DRACHMAN, D. B., K. R. MCINTOSH, S. DE SILVA, R. W. KUNCL & C. KAHN. 1988. Strategies for the treatment of myasthenia gravis. Ann. N.Y. Acad. Sci. 540: 176-186.
6. WEINER, H. L., A. FRIEDMAN, A. MILLER, S. J. KHOURY, A. AL-SABBAGH, L. SANTOS, M. SAYEGH, R. B. NUSSENBLATT, D. A. TRENTHAM & D. A. HAFLER. 1994. Oral tolerance: Immunologic mechanisms and treatment of murine and human organ specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12: 809.
7. DICK, A. D., Y. F. CHENG, A. MCKINNON, J. LIVERSIDGE & J. V. FORRESTER. 1993. Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Br. J. Ophthalmol. 77: 171.
8. LINK, J., M. SÖDERSTRÖM, Å. LJUNGDAHL, B. HÖJEBERG, T. OLSSON, Z. XU, S. FREDRIKSON, Z. Y. WANG & H. LINK. 1994. Organ-specific autoantigans induce IFN-γ and IL-4 mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Neurology 44: 728.
9. MILLER, A., O. LIDER, A. B. ROBERTS, M. B. SPRON & H. L. WEINER. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β following antigen-specific triggering. Proc. Natl. Acad. Sci. USA 89: 421.
10. SIMMONS, R. D. & D. O. WILLENBORG. 1990. Direct injection of cytokines into the spinal cord causes autoimmune encephalomyelitis-like inflammation. J. Neurol. Sci. 100: 37.
11. MUSTAFA, M. I., P. DIENER, B. HÖJEBERG, P. VAN DER MEIDE & T. OLSSON. 1991. T cell immunity and interferon-γ secretion during experimental allergic encephalomyelitis in Lewis rats. J. Neuroimmunol. 31: 165.
12. LINK, H., O. OLSSON, J. B. SUN, W. Z. WANG, G. ANDERSSON, H. P. EKRE, T. BRENNER, O. ABRAMSKY & T. OLSSON. 1991. Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls. J. Clin. Invest. 87: 2191.
13. HAMEL, C. P., B. DETRICK & J. J. HOOKS. 1990. Evaluation of Ia expression in rat ovular tissues following inoculation with interferon-gamma. Exp. Eye Res. 50: 173.
14. SCHATTNER, A. 1994. Lymphokines in autoimmunity - a critical review. Clin. Immunol. Immunopathol. 70: 177.
15. GU, D., L. WOGENSEN, N. A. CALCUTT, G. XIA, S. ZHU, J. P. MERLIE, H. S. FOX, J. LINDSTROM, H. C. POWELL & N. SARVETNICK. 1995. Myasthenia gravis-like syndrome induced by expression of interferon γ in the neuromuscular junction. J. Exp. Med. 181: 547.
16. SKOSKIEWICZ, M. H., R. B. CALLIN, E. E. STERNBERGER & P. S. RUSSEL. 1985. Widespread and selective induction of major histocompatibility complex determined antigens in vivo by y interferon. J. Exp. Med. 162: 1645.
17. SIDMAN, C. L., J. D. MAXWELL, L. D. SCHULTZ, W. P. GRAY & H. M. JOHNSON. 1984. γ-Interferon is one of several direct B cell-maturing lymphokines. Nature 309: 801.
18. COLLART, M. A., J. BELIN, D. VASSALLI, S. DE KOSSODO & P. VASSALLI. 1986. Gamma-interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin-1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164: 2113.
19. NAKANO, S. & A. G. ENGEL. 1993. Myasthenia gravis: quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients. Neurology 43: 1167.
20. FINKELMAN, F. D. & J. HOLMES. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8: 303.
21. LINK, J., V. NAVIKAS, M. YU, S. FREDRIKSON, P. O. OSTERMAN & H. LINK. 1994. Augmented interferon-γ, interleukin-4 and transforming growth factor-β mRNA expression in blood mononuclear cells in myasthenia gravis. J. Neuroimmunol. 51: 185.
22. SASAKI, H., R. B. POLLARD, D. SCHMTTT & F. SUZUKI. 1992. Transforming growth factor-β in the regulation of the immune response. Clin. Immunol. Immunopathol. 65: 1.
23. KEHRL, J. H., C. THEVENIN, P. RIECKMANN & A. S. FAUCI. 1991. Transforming growth factor-β suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. J. Immunol. 146: 4016.
24. KEHRL, J. H., L. D. WAKEFIELD, A. B. ROBERTS, S. JAKOWLEW, M. ALVAREZ-MON, R. DERYNCK, M. B. SPORN & A. S. FAUCI. 986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163: 1037.
25. STEVENS, D. B., K. E. GOULD & R. H. SWANBORG. 1994. Transforming growth factor-β1 inhibits tumor necrosis factor-α/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis. J. Neuroimmunol. 51: 77.
26. KIM, K. J., J. ABRAMS & M. ALPHONSO. 1990. Role of endogenously produced interleukin-6 as a second signal in murine thymocyte proliferation induced by multiple cytokines: regulatory effects of transforming growth factor-β1. Cell. Immunol. 131: 261.
27. CZARNIECKI, C. W., H. H. CHIU, G. W. WONG, S. M. MCCABE & M. A. PALLADINO. 1988. Transforming growth factor-β1 modulates the expression of class II histocompatibility antigens on human cells. J. Immunol. 140: 4217.
28. GAMBLE, J. R. & M. A. VADAS. 1991. Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor-β. J. Immunol. 146: 1149.
29. LINK, J., S. FREDRIKSON, M. SÖDERSTRÖM, T. OLSSON, B. HÖJEBERG, Å. LJUNGDAHL & H. LINK. 1994. Organ-specific autoantigens induce transforming growth factor-β mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Ann. Neurol. 35: 197.
30. 1 suppresses autoantigen-induced expression of proinflammatory cytokines but not IL-10 in multiple sclerosis and myasthenia gravis. J. Neuroimmunol. 58: 21.